明天题材前瞻:贵金属暴涨打响避险战,全球巨头押注创新药
Sou Hu Cai Jing·2026-01-12 13:26

Group 1 - The geopolitical risks and policy uncertainties are enhancing the safe-haven attributes of precious metals, with silver futures surging by 6.00% and gold prices rising significantly due to increased demand for safe-haven assets [1] - The European Commission is prepared to impose new and stricter sanctions on Iran, escalating geopolitical tensions, while the independence of the Federal Reserve's policies is under scrutiny, further reinforcing gold's role as a traditional risk hedge [1] - Precious metals like gold and silver are expected to maintain an upward price trajectory amid a complex macroeconomic environment [1] Group 2 - Rongchang Biopharmaceutical announced a significant exclusive licensing agreement with AbbVie for a novel bispecific antibody drug, RC148, which will yield an upfront payment of $650 million and potential milestone payments up to $4.95 billion [1] - This transaction highlights the growing recognition of competitive domestic innovative biopharmaceuticals by international pharmaceutical giants, showcasing the improved negotiation power of domestic companies [1] - The deal is expected to encourage more domestic innovative drug companies to deepen their efforts in cutting-edge treatment areas such as oncology and autoimmune diseases, accelerating their internationalization through licensing collaborations [1] Group 3 - The Guangzhou Futures Exchange has implemented strict regulations on lithium carbonate futures trading, limiting clients who exceed opening limits to prevent excessive speculation and maintain market order [2] - This regulatory action aims to ensure that lithium carbonate futures prices reflect true supply and demand dynamics, promoting compliance among industry players and investors [2] - The focus is shifting from supply pressure to consumer-driven demand, indicating a robust performance in the demand side of the lithium market [2] Group 4 - The commercial aerospace sector is experiencing heightened attention, with several companies issuing announcements to warn about risks associated with stock price volatility [2] - Platinum Technology noted that the commercial aerospace development stage is still early, contributing limited revenue to the company in the coming years [2] - Other companies, such as Zhongke Star Map, indicated that the current stock price surge is not aligned with the actual performance of their commercial aerospace business, highlighting significant risks of detachment from fundamentals [2]

明天题材前瞻:贵金属暴涨打响避险战,全球巨头押注创新药 - Reportify